Pharmaceutical Drug Delivery - Global Market Outlook (2020-2028)

Pharmaceutical Drug Delivery - Global Market Outlook (2020-2028)

According to Stratistics MRC, the Global Pharmaceutical Drug Delivery Market is accounted for $1,430.50 billion in 2020 and is expected to reach $2,871.35 billion by 2028 growing at a CAGR of 9.1% during the forecast period. Factors such as rise in healthcare expenditure, growing concern and awareness about healthcare, and government support for research in the field of drug delivery are driving the growth of the market. However, risk of needlestick injuries is hampering the growth of the market.

A pharmaceutical drug delivery is a formulation or a device, which is employed for the administration of a therapeutic substance into the body. It functions by deploying medications to specifically targeted parts of the body by the aid of a medium, which can control the administration of the therapy by the means of either a physiological or chemical trigger. It is used to improve the efficacy and safety of an administered drug by controlling the rate, time, and site of release of drug in the body.

Based on the route of administration, the injectable drug delivery segment is anticipated to expand at a rapid pace during the forecast period owing to the increasing prevalence of chronic diseases, growing demand for biosimilar products, and low cost of devices. By geography, North America is going to have high growth during the forecast period which can be attributed to the increasing patient compliance to innovative drug delivery technologies and the presence of a large number of prominent players in this region.

Some of the key players profiled in the Pharmaceutical Drug Delivery Market include Teva Pharmaceuticals, Sanofi, Pfizer, Inc., Bristol-Myers Squibb, Novartis AG , Merck & Co., Inc., Becton, Amgen, F. Hoffman-La Roche, Eli Lilly and Company, Dickinson and Company, Antares Pharma, Inc, Boehringer Ingelheim, Johnson & Johnson, Inc., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Genmab A/S, AbbVie, 3M Company, and Gilead Sciences, Inc.

Routes of Administration Covered:
• Injectable Drug Delivery
• Oral Drug Delivery
• Ocular Drug Delivery
• Topical Drug Delivery
• Nasal Drug Delivery
• Pulmonary Drug Delivery
• Implantable Drug Delivery
• Transmucosal Drug Delivery

Applications Covered:
• Cardiovascular Diseases
• Respiratory Diseases
• Cancer
• Infectious Diseases
• Diabetes
• Central Nervous System Disorders
• Autoimmune Diseases
• Other Applications

End Users Covered:
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Home Care Settings

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pharmaceutical Drug Delivery Market, By Route of Administration
5.1 Introduction
5.2 Injectable Drug Delivery
5.2.1 Self-Injection Devices
5.2.1.1 Wearable Injectors
5.2.1.2 Pen Injectors
5.2.1.3 Needle-Free Injectors
5.2.1.4 Autoinjectors
5.2.2 Conventional Injection Devices
5.2.2.1 Product
5.2.2.1.1 Prefilled Syringes
5.2.2.1.2 Fillable Syringes
5.2.2.2 Usability
5.2.2.2.1 Disposable Syringes
5.2.2.2.2 Reusable Syringes
5.2.2.3 Material
5.2.2.3.1 Plastic
5.2.2.3.2 Glass
5.3 Oral Drug Delivery
5.3.1 Liquid Oral Drugs
5.3.1.1 Solutions
5.3.1.2 Syrups
5.3.2 Semi-Solid Oral Drugs
5.3.2.1 Elixirs
5.3.2.2 Emulsions
5.3.2.3 Gels
5.3.3 Solid Oral Drugs
5.3.3.1 Tablets
5.3.3.2 Powders
5.3.3.3 Pills
5.3.3.4 Capsules
5.4 Ocular Drug Delivery
5.4.1 Ocular Semi-Solid Formulations
5.4.1.1 Eye Ointments
5.4.1.2 Gels
5.4.2 Ocular Ocular Devices
5.4.2.1 Ocular Inserts
5.4.2.2 Drug-Coated Contact Lenses
5.4.3 Ocular Liquid Formulations
5.4.3.1 Liquid Sprays
5.4.3.2 Eye Drops
5.5 Topical Drug Delivery
5.5.1 Topical Liquid Formulations
5.5.1.1 Suspensions
5.5.1.2 Solutions
5.5.2 Topical Transdermal Products
5.5.2.1 Transdermal Gels
5.5.2.2 Transdermal Patches
5.5.3 Topical Semi-Solid Formulations
5.5.3.1 Pastes
5.5.3.2 Ointments
5.5.3.3 Lotions
5.5.3.4 Gels
5.5.3.5 Creams
5.5.4 Topical Solid Formulations
5.5.4.1 Powders
5.5.4.2 Suppositories
5.6 Nasal Drug Delivery
5.6.1 Nasal Sprays
5.6.2 Nasal Powders
5.6.3 Nasal Gels
5.6.4 Nasal Drops
5.7 Pulmonary Drug Delivery
5.7.1 Dry Powder Inhaler
5.7.2 Metered-Dose Inhaler
5.7.3 Nebulizers
5.7.3.1 Ultrasonic Nebulizers
5.7.3.2 Soft Mist Nebulizers
5.7.3.3 Jet Nebulizers
5.8 Implantable Drug Delivery
5.8.1 Passive Implantable Drug Delivery
5.8.2 Active Implantable Drug Delivery
5.9 Transmucosal Drug Delivery
5.9.1 Oral Formulations
5.9.1.1 Sublingual Drug Delivery
5.9.1.2 Buccal Drug Delivery
5.9.2 Other Transmucosal Drug Delivery Technologies
5.9.2.1 Vaginal Transmucosal Drug Delivery
5.9.2.2 Rectal Transmucosal Drug Delivery
6 Global Pharmaceutical Drug Delivery Market, By Application
6.1 Introduction
6.2 Cardiovascular Diseases
6.3 Respiratory Diseases
6.4 Cancer
6.5 Infectious Diseases
6.6 Diabetes
6.7 Central Nervous System Disorders
6.8 Autoimmune Diseases
6.9 Other Applications
6.9.1 Endocrine Disorders
6.9.2 Ophthalmic Disorders
7 Global Pharmaceutical Drug Delivery Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Diagnostic Centers
7.4 Ambulatory Surgery Centers/Clinics
7.5 Home Care Settings
8 Global Pharmaceutical Drug Delivery Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Teva Pharmaceuticals
10.2 Sanofi
10.3 Pfizer, Inc.
10.4 Bristol-Myers Squibb
10.5 Novartis AG
10.6 Merck & Co., Inc.
10.7 Becton
10.8 Amgen
10.9 F. Hoffman-La Roche
10.10 Eli Lilly and Company
10.11 Dickinson and Company
10.12 Antares Pharma, Inc
10.13 Boehringer Ingelheim
10.14 Johnson & Johnson, Inc.
10.15 GlaxoSmithKline plc
10.16 Bayer AG
10.17 AstraZeneca
10.18 Genmab A/S
10.19 AbbVie
10.20 3M Company
10.21 Gilead Sciences, Inc.
List of Tables
Table 1 Global Pharmaceutical Drug Delivery Market Outlook, By Region (2019-2028) ($MN)
Table 2 Global Pharmaceutical Drug Delivery Market Outlook, By Route of Administration (2019-2028) ($MN)
Table 3 Global Pharmaceutical Drug Delivery Market Outlook, By Injectable Drug Delivery (2019-2028) ($MN)
Table 4 Global Pharmaceutical Drug Delivery Market Outlook, By Self-Injection Devices (2019-2028) ($MN)
Table 5 Global Pharmaceutical Drug Delivery Market Outlook, By Conventional Injection Devices (2019-2028) ($MN)
Table 6 Global Pharmaceutical Drug Delivery Market Outlook, By Oral Drug Delivery (2019-2028) ($MN)
Table 7 Global Pharmaceutical Drug Delivery Market Outlook, By Liquid Oral Drugs (2019-2028) ($MN)
Table 8 Global Pharmaceutical Drug Delivery Market Outlook, By Semi-Solid Oral Drugs (2019-2028) ($MN)
Table 9 Global Pharmaceutical Drug Delivery Market Outlook, By Solid Oral Drugs (2019-2028) ($MN)
Table 10 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Drug Delivery (2019-2028) ($MN)
Table 11 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Semi-Solid Formulations (2019-2028) ($MN)
Table 12 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Ocular Devices (2019-2028) ($MN)
Table 13 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Liquid Formulations (2019-2028) ($MN)
Table 14 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Drug Delivery (2019-2028) ($MN)
Table 15 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Liquid Formulations (2019-2028) ($MN)
Table 16 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Transdermal Products (2019-2028) ($MN)
Table 17 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Semi-Solid Formulations (2019-2028) ($MN)
Table 18 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Solid Formulations (2019-2028) ($MN)
Table 19 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Drug Delivery (2019-2028) ($MN)
Table 20 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Sprays (2019-2028) ($MN)
Table 21 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Powders (2019-2028) ($MN)
Table 22 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Gels (2019-2028) ($MN)
Table 23 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Drops (2019-2028) ($MN)
Table 24 Global Pharmaceutical Drug Delivery Market Outlook, By Pulmonary Drug Delivery (2019-2028) ($MN)
Table 25 Global Pharmaceutical Drug Delivery Market Outlook, By Dry Powder Inhaler (2019-2028) ($MN)
Table 26 Global Pharmaceutical Drug Delivery Market Outlook, By Metered-Dose Inhaler (2019-2028) ($MN)
Table 27 Global Pharmaceutical Drug Delivery Market Outlook, By Nebulizers (2019-2028) ($MN)
Table 28 Global Pharmaceutical Drug Delivery Market Outlook, By Implantable Drug Delivery (2019-2028) ($MN)
Table 29 Global Pharmaceutical Drug Delivery Market Outlook, By Passive Implantable Drug Delivery (2019-2028) ($MN)
Table 30 Global Pharmaceutical Drug Delivery Market Outlook, By Active Implantable Drug Delivery (2019-2028) ($MN)
Table 31 Global Pharmaceutical Drug Delivery Market Outlook, By Transmucosal Drug Delivery (2019-2028) ($MN)
Table 32 Global Pharmaceutical Drug Delivery Market Outlook, By Oral Formulations (2019-2028) ($MN)
Table 33 Global Pharmaceutical Drug Delivery Market Outlook, By Other Transmucosal Drug Delivery Technologies (2019-2028) ($MN)
Table 34 Global Pharmaceutical Drug Delivery Market Outlook, By Application (2019-2028) ($MN)
Table 35 Global Pharmaceutical Drug Delivery Market Outlook, By Cardiovascular Diseases (2019-2028) ($MN)
Table 36 Global Pharmaceutical Drug Delivery Market Outlook, By Respiratory Diseases (2019-2028) ($MN)
Table 37 Global Pharmaceutical Drug Delivery Market Outlook, By Cancer (2019-2028) ($MN)
Table 38 Global Pharmaceutical Drug Delivery Market Outlook, By Infectious Diseases (2019-2028) ($MN)
Table 39 Global Pharmaceutical Drug Delivery Market Outlook, By Diabetes (2019-2028) ($MN)
Table 40 Global Pharmaceutical Drug Delivery Market Outlook, By Central Nervous System Disorders (2019-2028) ($MN)
Table 41 Global Pharmaceutical Drug Delivery Market Outlook, By Autoimmune Diseases (2019-2028) ($MN)
Table 42 Global Pharmaceutical Drug Delivery Market Outlook, By Other Applications (2019-2028) ($MN)
Table 43 Global Pharmaceutical Drug Delivery Market Outlook, By Endocrine Disorders (2019-2028) ($MN)
Table 44 Global Pharmaceutical Drug Delivery Market Outlook, By Ophthalmic Disorders (2019-2028) ($MN)
Table 45 Global Pharmaceutical Drug Delivery Market Outlook, By End User (2019-2028) ($MN)
Table 46 Global Pharmaceutical Drug Delivery Market Outlook, By Hospitals (2019-2028) ($MN)
Table 47 Global Pharmaceutical Drug Delivery Market Outlook, By Diagnostic Centers (2019-2028) ($MN)
Table 48 Global Pharmaceutical Drug Delivery Market Outlook, By Ambulatory Surgery Centers/Clinics (2019-2028) ($MN)
Table 49 Global Pharmaceutical Drug Delivery Market Outlook, By Home Care Settings (2019-2028) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings